British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:British Columbia Cancer Agency - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011923
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy, chemotherapy services, nursing care, patient and family counseling, nutrition counseling, pharmacy services, pain and symptom control service, teaching and applied research activities and cancer information library. Its cancer care program includes prevention, screening and early detection, diagnosis and treatment services, support programs, community programs, research and education. BC Cancer Agency partners with communities to provide a network of chemotherapy clinics. It operates through its various centers across Canada. BC Cancer Agency is headquartered in Vancouver, British Columbia, Canada.

British Columbia Cancer Agency – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
British Columbia Cancer Agency, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
British Columbia Cancer Agency, Medical Devices Deals, 2011 to YTD 2017 9
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 11
Charles River Labs Enters into Agreement with British Columbia Cancer Agency 12
Licensing Agreements 13
Coastal Genomics Enters Into Licensing Agreement With BC Cancer Agency For Liquid Handling Automation Technology 13
British Columbia Cancer Agency – Key Competitors 14
British Columbia Cancer Agency – Key Employees 15
British Columbia Cancer Agency – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Oct 05, 2017: Better understanding of bladder cancer subtypes might lead to improved treatments 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Key Facts 2
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
British Columbia Cancer Agency, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
British Columbia Cancer Agency, Deals By Therapy Area, 2011 to YTD 2017 8
British Columbia Cancer Agency, Medical Devices Deals, 2011 to YTD 2017 9
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 11
Charles River Labs Enters into Agreement with British Columbia Cancer Agency 12
Coastal Genomics Enters Into Licensing Agreement With BC Cancer Agency For Liquid Handling Automation Technology 13
British Columbia Cancer Agency, Key Competitors 14
British Columbia Cancer Agency, Key Employees 15
British Columbia Cancer Agency, Other Locations 16

★海外企業調査レポート[British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sokolovska uhelna, pravni nastupce, A.S.:企業の戦略的SWOT分析
    Sokolovska uhelna, pravni nastupce, A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Link Health Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Link Health Group (Link Health) is a pharmaceutical company focused on the discovery and development of novel drug candidates for the treatment of cancer and other diseases. Its pipeline product portfolio includes LH011, an oral small molecule serine protease inhibitor for treating pancreati …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • DISH Network Corp (DISH):企業の財務・戦略的SWOT分析
    DISH Network Corp (DISH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Goals Soccer Centres plc:企業の戦略的SWOT分析
    Goals Soccer Centres plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Allegheny Technologies Incorporated:企業の戦略・SWOT・財務情報
    Allegheny Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Allegheny Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • University of Arizona-医療機器分野:企業M&A・提携分析
    Summary University of Arizona (UA) is a healthcare research university that offers undergraduate and graduate degrees. The university’s academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for education …
  • Pentair Plc (PNR):電力:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Safaricom Ltd:企業の戦略・SWOT・財務分析
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ImaBiotech SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that offers mass spectrometry imaging services. The organization’s software products include quantinetix and multimaging. It offers services such as biomarker discovery, consulting and training, screening studies, target engagem …
  • Sumitomo Corp (8053):企業の財務・戦略的SWOT分析
    Sumitomo Corp (8053) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Impact Developer & Contractor SA:企業の戦略・SWOT・財務情報
    Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report Summary Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bear Creek Mining Corp (BCM):企業の財務・戦略的SWOT分析
    Summary Bear Creek Mining Corp (Bear Creek) is a silver exploration and development company. The company's projects include Santa Ana project and Corani project. Its Corani project located in the Andes Mountains of Peru and explores for silver, lead, zinc deposit. Bear Creek also conducts silver and …
  • Peakdale Molecular Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Peakdale Molecular Ltd (Peakdale), a subsidiary of Concept Life Sciences Ltd, is a company that offers drug discovery services. It service portfolio offers services including drug discovery, nucleoside chemistry, materials chemistry and research support services. Peakdale offers research sup …
  • Saras S.p.A. (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Xylem Inc.:企業の戦略・SWOT・財務情報
    Xylem Inc. - Strategy, SWOT and Corporate Finance Report Summary Xylem Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆